Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peg Intron for relapsed hematological malignancies post-alloHSCT
NCT02634294Phase 3Completed
- Sponsor
- Shanghai General Hospital
- Start
- Aug 2015
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b in hematological neoplasms, sponsored by Shanghai General Hospital. Started Aug 2015; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hematological neoplasms
Beyond the preview
Go deeper on NCT02634294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634294.